prevention Archives - ACR Meeting Abstracts

Abstract Number: 0165 • ACR Convergence 2026
Data driven machine learning model for long-term mortality prediction in Takayasu Arteritis
Aïcha Kante¹, Solenn Toupin², Patrice Cacoub³, MEKINIAN Arsene⁴, Tristan Mirault⁵, Damien Sène⁶, Karine Champion¹, Stéphane Mouly¹, Matthieu Groh⁷, Félix Ackermann⁸, Maxime SAMSON⁹, Bertrand Bonnotte⁹, Paul Legendre¹⁰, Marc Lambert¹¹, Christian Agard¹², Alexandra Audemard-Verger¹³, Nicole Ferreira-Maldent¹⁴, Cedric Mercuzot¹⁵, Camille Roubille¹⁵, Ygal Benhamou¹⁶, Olivier Espitia¹², Hubert De Boysson¹⁷, David Saadoun⁶, Théo Pezel² and Cloé Comarmond¹⁸ Affiliations: ¹Department of Internal Medicine and Clinical Immunology, AP-HP, Lariboisière University Hospital, Paris, France, Paris, France, ²Department of Cardiology, AP-HP, Lariboisière University Hospital, Paris, France, Paris, France, ³Internal Medicine and Clinical Immunology Department, AP-HP, Pitié-Salpêtrière Hospital, Paris, France, PARIS, France, ⁴Internal Medicine Department, Saint Antoine Hospital, APHP, Sorbonne University, Paris, France, ⁵Service de Médecine Vasculaire et Centre de Référence des Maladies Artérielles Rares, AP-HP, Hôpital Européen Georges-Pompidou, Paris, France, Paris, France, ⁶APHP, Paris, France, ⁷Internal Medicine Department, Clinical Immunology and Hematology, Foch Hospital, National Reference Center for Hypereosinophilic Syndromes, Versailles Saint Quentin-en-Yvelines University, Surenes, France, ⁸Internal Medicine Department, Foch Hospital, Suresnes, France, ⁹Université Bourgogne Europe, CHU Dijon Bourgogne, Department of Internal Medicine and Clinical Immunology, Referral Center for Rare Systemic Autoimmune and Autoinflammatory Diseases, INSERM U1098, F-CRIN CRI-IMIDIATE network, Dijon, France, Dijon, France, ¹⁰Internal Medicine Department, Le Mans Hospital, Le Mans, France, ¹¹Department of Internal Medicine, Hôpital Claude Huriez, Lille, France, Lille, France, ¹²Service de Médecine Interne, Hôtel-Dieu, Centre Hospitalier Universitaire, Nantes, France, Nantes, France, ¹³Department of Internal Medicine and Clinical Immunology, CHRU Tours, University of Tours, Tours, France, Tours, France, ¹⁴Department of Internal Medicine and Clinical Immunology, CHRU Tours, University of Tours, Tours, France, Tours, ¹⁵Department of Internal Medicine, CHU Montpellier, Montpellier University Montpellier France, Montpellier, France, ¹⁶Bois Guillaume University Hospital, Rouen, France, Paris, France, ¹⁷Caen university Hospital, Caen, France, ¹⁸Department of Internal Medicine and Clinical Immunology, AP-HP,Lariboisière Hospital, AP-HP, Paris, France, Paris, France
Background/Purpose: Takayasu arteritis (TAK) is a large vessel vasculitis that predominantly affects young women and is associated with increased mortality. Existing prognostic scores are seldom…
Abstract Number: 1773 • ACR Convergence 2026
Assessing Barriers to Recombinant Zoster Vaccination in Immunosuppressed Adults: Baseline Data and Quality Improvement Planning For an Academic Rheumatology Clinic.
Joshua Cohen¹, Christian Volckaert¹, Scot Sternberg¹ and Tara Skorupa² Affiliations: ¹Beth Israel Deaconess Medical Center, Brookline, MA, ²Beth Israel Deaconess Medical Center, Boston, MA
Background/Purpose: Immunocompromised patients are at increased risk of multiple vaccine-preventable infections, including reactivation of herpes zoster. Current guidelines recommend the recombinant Zoster vaccine (RZV) for…
Abstract Number: 2861 • ACR Convergence 2026
Performance of the PREVENT Risk Assessment Calculator for Predicting Heart Failure in Patients with Systemic Lupus Erythematosus
Aakash V. Patel¹, Lingxiao Zhang², Emily S. Lau³, Hyon K. Choi⁴ and April Jorge⁵ Affiliations: ¹Division of Rheumatology, Inflammation, and Immunity, Massachusetts General Hospital and Mass General Brigham and Harvard Medical School, Boston, MA, ²Massachusetts General Hospital, Malden, MA, ³Mass General Brigham Heart & Vascular Institute and Harvard Medical School, Boston, ⁴Division of Rheumatology, Inflammation, and Immunity, Massachusetts General Hospital and Mass General Brigham and Harvard Medical School, Lexington, MA, ⁵Massachusetts General Hospital, Boston, MA
Background/Purpose: Patients with systemic lupus erythematosus (SLE) are at increased risk for heart failure. We assessed the performance of the recently validated Predicting Risk of…
Abstract Number: 0522 • ACR Convergence 2026
Insights into Lupus Research Participation from Patient and Family Voices: A Thematic Analysis of Involvement in Lupus Prevention Research
Maura Iversen¹, emily Oakes², Norioscar Cabello², Candace Feldman³, Misti L Paudel⁴ and Karen Costenbader⁵ Affiliations: ¹Johnson & Wales University, East falmouth, MA, ²Brigham & Women's Hospital, Boston, MA, ³Brigham and Women's Hospital & Harvard Medical School, Boston, MA, ⁴Brigham and Women's Hospital, Division of Rheumatology, Inflammation, and Immunity, Boston, MA, ⁵Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA, BOSTON, MA
Background/Purpose: Patient and first-degree relative (FDR) perspectives on research participation may inform the design of future SLE prevention studies. We aimed to elicit perspectives on…
Abstract Number: 1778 • ACR Convergence 2026
Coccidiomycosis Screening in Rheumatology Patients at a California Academic Medical Center
Ivan Herrera, Matthew Cappiello, Fakhar Abbas and Christina Downey Affiliations: Loma Linda University Medical Center, Loma Linda
Background/Purpose: Coccidioidomycosis has a high incidence in the American Southwest, notably increased among patients receiving immunosuppressive therapies. Prior literature has emphasized the importance of coccidioidomycosis…
Abstract Number: 2900 • ACR Convergence 2026
Real-World Evidence on the Use of Statins in Patients With Rheumatoid Arthritis at Increased Risk for Cardiovascular Disease
Jon Giles¹, Emily Scherer², Madhawa Saranadasa³, Carrie Huisingh³, Musaab Gari³, Gregory Markley⁴ and Christina Charles-Schoeman⁵ Affiliations: ¹Kao Autoimmunity Institute and Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, ²AbbVie Inc., North Chicago, IL, ³AbbVie, North Chicago, IL, ⁴AbbVie, North Chicago, ⁵UCLA Medical Center, Los Angeles, CA
Background/Purpose: ORAL Surveillance, a post-authorization safety study comparing tofacitinib to TNF inhibitors, reported a higher incidence of major adverse cardiovascular events in patients with rheumatoid…
Abstract Number: 0535 • ACR Convergence 2026
Knowledge, Attitudes, and Practices Regarding Cervical Cancer Prevention and Screening Among Women With Systemic Lupus Erythematosus: A Multicenter Cross-sectional Survey
In Ah Choi¹, Sung-Hoon Park², Yeon-Ah Lee³, Hanna Lee⁴, Young Ho Lee¹, Chang Hee Suh⁵, Seung Cheol Shim⁶, So-Young Bang⁷, Sung-Hwan Park⁸, Seung Min Jung⁹, Yoon-Kyoung Sung¹⁰, Yong-Gil Kim¹¹ and Jisoo Lee¹² Affiliations: ¹Korea University, Seoul, Republic of Korea, ²Daegu Catholic University School of Medicine, Daegu, Republic of Korea, ³Kyung Hee University Medical Center, Seoul, Republic of Korea, ⁴Gyeongsang National University, Jinju, Republic of Korea, ⁵Department of Rheumatology, Ajou University School of Medicine, Suwon, Republic of Korea, ⁶Chungnam National University, Daejeon, Republic of Korea, ⁷Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea, ⁸Division of Rheumatology, Department of Internal Medicine, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea, seoul, Republic of Korea, ⁹The Catholic University of Korea, St. Vincent's Hospital, Suwon, Republic of Korea, ¹⁰Hanyang University Hospital for Rheumatic Diseases, SEOUL, Republic of Korea, ¹¹Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, Songpa-gu, Seoul-t'ukpyolsi, Republic of Korea, ¹²Division of Rheumatology, Department of Internal Medicine, Ewha Womans University College of Medicine, SEOUL, Republic of Korea
Background/Purpose: Cervical cancer is largely preventable through human papillomavirus (HPV) vaccination and early detection by screening. Women with systemic lupus erythematosus (SLE) have an increased…
Abstract Number: 1821 • ACR Convergence 2026
Molecular Heterogeneity in Preclinical Lupus: Distinct Longitudinal Proteomic Trajectories Preceding Disease Progression
Benjamin Jones¹, Rufei Lu¹, Alexandre Cammarata-Mouchtouris¹, Carla Guthridge¹, Susan Macwana¹, Wade DeJager¹, Nancy Olsen², David Karp³, Judith James⁴ and Joel Guthridge⁴ Affiliations: ¹Oklahoma Medical Research Foundation, Oklahoma City, OK, ²Penn State University/Milton S Hershey, Hershey, PA, ³UT Southwestern Medical Center, Dallas, TX, ⁴Oklahoma Medical Research Foundation and University of Oklahoma Health Campus, Oklahoma City, OK
Background/Purpose: A positive ANA with variable clinical features is one of the most common referrals to rheumatology clinics, yet only a subset of these individuals…
Abstract Number: 2902 • ACR Convergence 2026
North American Expert Consensus on Atherosclerotic Cardiovascular Disease Risk Screening and Management in Adults with Lupus Nephritis
Shivani Garg¹, Brad Rovin², Amish Raval³, Jane Pearson³, Caroline Packee⁴, Jennifer Barton⁵, Brad Astor⁶, Rupali Avasare⁷, Udayan Bhatt⁸, Vaidehi Chowdhary⁴, Gaia Coppock⁹, Kimberly DeQuattro¹⁰, Attila Feher¹¹, Candace Feldman¹², Shraddha Jatwani¹³, Margaret Furman⁴, Maranda Pogue¹⁴, Maureen McMahon¹⁵, Wambui Machua¹⁶, KURT OELKE¹⁷, Zahraa Qamhieh¹⁸, Alexa Dreyfus³, Isabella Hartel³, Yesenia Santiago Casas¹⁹, Kai Sun²⁰, Konstantinos Tselios²¹, Melissa Vue²², Jessica Williams²³, Brittany Weber²⁴, Murray Urowitz²⁵, Lisa Suter¹, S. Sam Lim²⁶ and Christie Bartels²⁷ Affiliations: ¹Yale School of Medicine, New Haven, CT, ²Ohio State University, Columbus, OH, ³UW-Madison, Madison, ⁴Yale University, New Haven, CT, ⁵Center to Improve Veteran Involvement in CARE (CIVIC), VA Portland Health Care System, Portland, OR, ⁶University of Wisconsin, Madison, Madison, ⁷Oregon Health Science University, Portland, ⁸Ohio State University, Colombus, ⁹University of Pennsylvania, Philadelphia, ¹⁰Stanford University, Palo Alto, CA, ¹¹Yale University School of Medicine - New Haven, CT, New Haven, CT, ¹²Brigham and Women's Hospital, Boston, MA, ¹³Dignity Health-MMG Rheumatology, Citrus Heights, CA, ¹⁴N/A, Dallas, TX, ¹⁵UCLA David Geffen School of Medicine, Los Angeles, CA, ¹⁶Piedmont Healthcare, Atlanta, GA, ¹⁷rheumatic disease center, Glendale, WI, ¹⁸University of Michigan, Ann arbor, MI, ¹⁹Holy Cross Medical Group, Fort Lauderdale, ²⁰Department of Medicine, Duke University School of Medicine, Durham, NC, ²¹McMaster University, Hamilton, ON, Canada, ²²NA, Madison, ²³Howard University College of Medicine, Washington, DC, ²⁴UTSW, Colleyville, TX, ²⁵Department of Medicine, University of Toronto, Toronto, ON, Canada, ²⁶Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, GA, ²⁷University of Wisconsin School of Medicine and Public Health, Madison, WI
Background/Purpose: Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of premature mortality in lupus nephritis (LN). ASCVD risk is up to 9x higher in LN compared…
Abstract Number: 0589 • ACR Convergence 2026
Trends in Annual Influenza and COVID-19 Vaccination in Childhood Systemic Lupus Erythematosus, 2024-2025
Arianna Peters¹, Andrea Hughes², Sophie Pan¹, Serena Valani¹, Kianna Castro¹ and Titilola Falasinnu² Affiliations: ¹Stanford University, Palo Alto, CA, ²Stanford University, Palo Alto
Background/Purpose: Vaccination remains the most effective strategy for preventing infectious diseases. Current ACR guidelines recommend annual influenza and updated COVID-19 vaccination for patients with rheumatic…
Abstract Number: 1836 • ACR Convergence 2026
Catching the window for interception in individuals at risk of developing inflammatory arthritis: design of a dynamic “Imminent Risk Score”.
Laurence Duquenne¹, Jacqueline Nam², Andrea Di Matteo², JianHua Wu³, Sana Sharrack⁴, Kate Harnden², Michele Stanciu⁵, Helen-Jayne Sugden⁴, Leticia Garcia Montoya⁶, Kulveer Mankia⁴ and Paul Emery⁴ Affiliations: ¹Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, United Kingdom, Leeds, United Kingdom, ²Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom, ³Wolfson Institute of Population Health/Queen Mary University of London, London, United Kingdom, ⁴University of Leeds, Leeds, United Kingdom, ⁵Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, ⁶LIRMM, Leeds, United Kingdom
Background/Purpose: In individuals at risk of developing inflammatory arthritis (IA), prediction scores are usually based on baseline assessments, yet progression can occur years later. We…
Abstract Number: 2970 • ACR Convergence 2026
Vaccination Knowledge, Attitudes, and Uptake Among Patients with Rheumatic Diseases Across Arabian Gulf Countries
Khalid A. Alnaqbi¹, Mohammad Khudadah², Roaa Aljohani³, Tariq Al Araimi⁴, Yaqeen Al Hajri⁵, Anwar Albasri⁶, Noura Alforaih⁷, Samar Al Emadi⁸, Omar Alsaeed⁹, Fatima Haji¹⁰ and Ghaydaa Aldabie¹¹ Affiliations: ¹Sheikh Tahnoon bin Mohammed Medical City, Al Ain, Abu Dhabi, United Arab Emirates, ²Farwaniya Hospital, kuwait, Kuwait, ³College of Medicine, Taibah University, Medina, Al Madinah, Saudi Arabia, ⁴Royal Hospital, Muscat, Oman, ⁵Ministry of Health, Muscat, Masqat, Oman, ⁶Ministry of Health, Kuwait, Kuwait, ⁷Amiri Hospital, Kuwait, Kuwait, ⁸Hamad medical corporation, Doha, Qatar, ⁹Hamad Medical Corporation, Doha, Qatar, ¹⁰Salmaniya Medical Complex, Manama, Bahrain, ¹¹ministry of health kuwait, kuwait, Kuwait
Background/Purpose: Patients with musculoskeletal and rheumatic diseases (RMD) are at increased risk of infection due to immune dysregulation and immunosuppressive therapy. Despite international vaccination recommendations,…
Abstract Number: 0596 • ACR Convergence 2026
Factors Associated with Favorable Oral Health Care Practices in People with Autoimmune and Inflammatory Rheumatic Diseases
Lesley Jackson¹, Rahima Begum², Mary Wilkenson², Kenneth Saag³, Emma Dunaway², Kristen Rutledge² and Maria I. ("Maio") Danila⁴ Affiliations: ¹University of Alabama at Birmingham, Vestavia, AL, ²University of Alabama at Birmingham, Birmingham, AL, ³The University of Alabama at Birmingham, Birmingham, AL, ⁴University of Alabama at Birmingham (UAB), Birmingham VA Medical Center, Birmingham, AL
Background/Purpose: Oral health practices among people living with autoimmune and inflammatory rheumatic disease (AIRD) remain understudied despite increased risk of periodontal disease and oral health…
Abstract Number: 2031 • ACR Convergence 2026
Baseline secretory component-containing ACPA levels in anti-CCP antibody positive individuals are predictive of future RA development but are not associated with periodontal disease status
Sana Sharrack¹, Kerem Abacar², Xia Yu³, Laurence Duquenne⁴, Jacqueline Nam⁵, Andrea Di Matteo⁶, Kate Harnden⁵, Helen-Jayne Sugden⁷, Lucy Thornton⁸, Michele Stanciu⁹, Zhain Mustufvi¹⁰, Ashna Chavda¹⁰, Sally Elsworth¹⁰, Farag Shuweihdi¹⁰, Sue Pavitt¹⁰, Klara Martinsson¹¹, Alf Kastbom¹², Paul Emery⁷, Josephine Meade³ and Kulveer Mankia⁷ Affiliations: ¹University of Leeds, Sheffield, United Kingdom, ²Marmara University, Istanbul, istanbul, Turkey, ³Division of Oral Biology, School of Dentistry, University of Leeds, United Kingdom, Leeds, United Kingdom, ⁴Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, United Kingdom, Leeds, United Kingdom, ⁵Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom, ⁶Polytechnic University of Marche, Jesi, Ancona, Italy, ⁷University of Leeds, Leeds, United Kingdom, ⁸University of Leeds, Shipley, United Kingdom, ⁹Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, ¹⁰School of Dentistry, Faculty of Medicine and Health, University of Leeds, United Kingdom, Leeds, United Kingdom, ¹¹Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Linköping University, Sweden, Linkoping, Sweden, ¹²Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Linköping University, Sweden, STOCKHOLM, Sweden
Background/Purpose: Periodontal disease (PD) may be a trigger for Rheumatoid Arthritis (RA) autoimmunity through localised anti-citrullinated protein antibody (ACPA) production, supported by evidence of IgA…
Abstract Number: 0681 • ACR Convergence 2026
Humoral responses to recombinant varicella-zoster virus vaccine in patients with chronic arthritis starting JAK inhibitor therapy
Raquel Zas Vaamonde¹, Alicia Usategui¹, Gabriel Criado Carrasco², Mayra A. Sigcha³, Isabel Hernández-Rodríguez¹, Purificacion MALDONADO BARAHONA³, Pilar Arrazola¹ and Jose L. Pablos⁴ Affiliations: ¹Hospital 12 de Octubre, Madrid, Spain, ²FIB Hospital 12 de Octubre, Madrid, Spain, ³Hospital 12 de Octubre, Madrid, Madrid, Spain, ⁴Hospital Universitario 12 de Octubre, Madrid, Madrid, Spain
Background/Purpose: Herpes zoster (HZ) is a frequent complication in chronic arthritis patients on JAK inhibitor (JAKi) therapy. The adjuvanted recombinant zoster vaccine (RZV, Shingrix) induces adequate but…

Abstracts tagged "prevention"